IDEAYA Biosciences Cash Flow Statement (2018-2026) | IDYA

Cash Flow Statement Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-11.07M-11.83M-20.88M-25.31M-37.92M-18.18M-25.33M-26.28M-33.68M-33.87M-39.17M-53.54M-161.44M-134.32M-147.26M-93.14M-135.42M30.15M-94.45M-232.76M
Share-based Compensation (Quarter)
2.06M2.20M2.06M2.60M3.04M3.00M2.98M3.66M4.73M5.30M18.49M6.31M9.73M9.21M9.48M96.20M11.87M108.40M-28.14M161.60M
Deferred Taxes (Quarter)
Cash from Operations (Quarter)
-12.93M-12.47M-16.66M-19.65M-19.99M-24.17M-23.37M-27.84M-33.46M-30.17M-23.75M-43.81M-32.88M-49.23M-121.66M-60.34M-62.47M142.21M-90.50M-75.17M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.45M-0.47M-0.47M-0.35M-0.17M0.09M1.13M1.56M2.55M3.57M3.88M6.31M6.64M5.36M4.92M3.78M2.69M1.98M1.52M1.21M
Amortization of Deferred Charges (Quarter)
0.33M0.34M0.34M0.35M0.36M0.36M0.37M0.38M0.39M0.40M0.47M0.47M0.43M0.07M0.53M0.52M0.37M0.48M0.46M
Depreciation & Amortization (CF) (Quarter)
0.44M0.45M0.45M0.46M0.51M0.57M0.56M0.59M0.62M0.64M0.63M0.62M0.62M0.58M0.57M0.60M0.72M0.66M0.72M0.69M
Change in Working Capital
Change in Receivables (Quarter)
-1.60M-0.31M0.09M-0.41M-0.41M3.16M-3.24M0.26M-0.31M6.54M-6.68M-0.00M-0.01M0.02M-0.00M
Change in Account Payables (Quarter)
0.54M0.38M-0.01M0.86M1.05M-0.45M0.40M-0.01M1.60M-0.70M1.75M-0.45M9.70M-3.94M2.98M2.73M-0.36M1.19M-0.86M3.05M
Change in Accured Expenses (Quarter)
2.34M2.01M0.48M0.14M2.96M1.15M0.32M-0.42M-2.84M2.41M2.48M-1.27M6.90M2.90M2.27M2.88M4.84M7.51M-4.80M2.73M
Other Working Capital Changes (Quarter)
-0.38M1.14M-1.94M-0.41M-0.42M-0.43M3.38M-1.37M3.88M-3.89M-0.49M3.13M-4.13M-0.28M-0.09M1.97M0.50M-0.19M0.28M0.69M
Investing Activities
Capital Expenditures (Quarter)
1.20M0.46M0.60M0.55M0.47M2.42M-3.06M0.75M-0.15M0.93M0.84M1.32M0.97M-1.02M0.20M0.65M1.34M-1.36M1.74M0.97M
Change in Acquisitions & Divestments (Quarter)
41.49M93.53M32.76M46.94M53.18M70.50M55.23M95.86M99.75M133.78M110.50M123.14M234.29M194.15M141.03M186.35M174.13M180.80M138.94M162.53M
Cash from Investing Activities (Quarter)
-49.38M-56.31M-0.41M-17.76M13.32M-18.68M-10.28M23.52M-121.38M51.35M-111.94M-353.97M68.56M-20.04M-197.11M79.82M45.92M41.77M-97.53M118.95M
Financing Activities
Other financing activities (Quarter)
0.24M-0.03M-0.33M0.66M-0.23M1.01M0.37M1.49M-1.22M0.58M5.46M2.08M1.86M-7.96M1.13M0.41M0.38M-0.43M1.19M
Cash from Financing Activities (Quarter)
15.99M86.78M0.69M0.65M0.49M95.70M0.32M2.93M191.06M27.83M140.89M349.11M39.18M286.50M2.75M26.14M1.21M0.30M2.13M1.18M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
15.40M28.69M0.05M-0.05M86.48M-0.38M2.56M-0.25M127.57M343.65M-343.65M379.94M-105.59M25.00M
Additional items
Change in Cash (Quarter)
-46.33M18.00M-16.38M-36.76M-6.18M52.85M-33.32M-1.40M36.22M49.01M5.20M-48.67M74.86M217.23M-316.01M45.62M-15.35M184.28M-185.89M44.96M
Free Cash Flow (Quarter)
-14.13M-12.93M-17.26M-20.20M-20.46M-26.59M-20.31M-28.59M-33.31M-31.10M-24.59M-45.14M-33.85M-48.21M-121.86M-61.00M-63.81M143.58M-92.23M-76.14M
Net Cash Flow (Quarter)
-46.33M18.00M-16.38M-36.76M-6.18M52.85M-33.32M-1.40M36.22M49.01M5.20M-48.67M74.86M217.23M-316.01M45.62M-15.35M184.28M-185.89M44.96M